Home  >  Speakers  >  Norman W. Baylor
Norman  W. Baylor

Norman W. Baylor

    
President, CEO | Alexandria, Virginia    United States Of America
Immunology And Microbiology
ImmunologyVaccines Research, Microbial Genetics,...More

Biography :

Dr. Norman W. Baylor is currently the President and CEO of BiologicsConsulting Group, Inc. He was formerly the Director of the Office of Vaccines Research and Review (OVRR) in the Food and Drug Administration’s Center for Biologics Evaluation and Research. Prior to his position as Director, Dr. Baylor served as Deputy Director of OVRR and Associate Director for Regulatory Policy. He has evaluated and facilitated the development and licensure of numerous new vaccines such as acellular pertussis, varicella, pneumococcal conjugate, human papillomavirus (HPV), influenza, Zoster and all of the new generation combination vaccines during his 20 year career at FDA. Dr. Baylor received his B.S. degree in medical microbiology from the University of Wisconsin, Madison, and his M.S. and Ph.D. degrees in microbial genetics and molecular microbiology, respectively from the University of Kentucky. Dr. Baylor pent three years as a postdoctoral fellow at the University of Virginia School of Medicine in the Department of Microbiology and Immunology, and 3 years with Program Resources Incorporated as a Senior Research Scientist at the National Cancer Institute-Frederick Cancer Research Facility. Dr. Baylor served as FDA’s liaison to CDC’s Advisory Committee on Immunization Practices, the US Department of Health and Human Services National Vaccine Advisory Committee, and the Advisory Commission on Childhood Vaccines. Dr. Baylor continues to serve as an expertadvisor to the World Health Organization on several global vaccine initiatives including assessing national regulatory authorities worldwide.

*******************
**********
 
For speaker's contact information - Contact us

Specialties

Immunology and Microbiology

Interested Topics

ImmunologyVaccines Research, Microbial genetics, Molecular microbiology, Virology, Infectious Diseases, Global public health, Biopharmaceuticals, Clinical Development, Drug Development, Technology Transfer, Drug Discovery,

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.

Appears with

  • This section has yet to be updated by the speaker.
X

Send Message

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.